The molecular mechanisms of copper metabolism and its roles in human diseases.
Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C.
Pflugers Arch. 2020 Oct;472(10):1415-1429. doi: 10.1007/s00424-020-02412-2. Epub 2020 Jun 7.
Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.
Guthrie LM, Soma S, Yuan S, Silva A, Zulkifli M, Snavely TC, Greene HF, Nunez E, Lynch B, De Ville C, Shanbhag V, Lopez FR, Acharya A, Petris MJ, Kim BE, Gohil VM, Sacchettini JC.
Science. 2020 May 8;368(6491):620-625. doi: 10.1126/science.aaz8899.
A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease.
Vairo FPE, Chwal BC, Perini S, Ferreira MAP, de Freitas Lopes AC, Saute JAM.
Mol Genet Metab. 2019 Jan;126(1):6-13. doi: 10.1016/j.ymgme.2018.12.005. Epub 2018 Dec 11.
Copper deficiency.
Madsen E, Gitlin JD.
Curr Opin Gastroenterol. 2007 Mar;23(2):187-92. doi: 10.1097/MOG.0b013e32801421bb.
Menkes disease.
Tümer Z, Møller LB.
Eur J Hum Genet. 2010 May;18(5):511-8. doi: 10.1038/ejhg.2009.187. Epub 2009 Nov 4.
Menkes disease.
Bertini I, Rosato A.
Cell Mol Life Sci. 2008 Jan;65(1):89-91. doi: 10.1007/s00018-007-7439-6.
Cellular copper transport.
Vulpe CD, Packman S.
Annu Rev Nutr. 1995;15:293-322. doi: 10.1146/annurev.nu.15.070195.001453.
Menkes disease.
Kaler SG.
Adv Pediatr. 1994;41:263-304.
Precious metal economy.
Merchant SS, Sagasti A.
Cell Metab. 2006 Aug;4(2):99-101. doi: 10.1016/j.cmet.2006.07.003.
Copper comes of age in Melbourne.
Mercer JF, Camakaris J.
Metallomics. 2016 Sep 1;8(9):816-23. doi: 10.1039/c6mt90022d. Epub 2016 Jul 11.
